Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Progyny ( (PGNY) ) has provided an update.
On April 9, 2025, Dr. Fred E. Cohen informed Progyny, Inc. that he will not seek reelection at the company’s 2025 Annual Meeting of Stockholders. His decision is not due to any disagreement with the company’s operations, policies, or practices, and he will remain a director until the end of his current term.
Spark’s Take on PGNY Stock
According to Spark, TipRanks’ AI Analyst, PGNY is a Outperform.
Progyny’s robust financial performance and positive technical indicators contribute significantly to its overall score. The company’s high P/E ratio suggests a premium valuation, while recent earnings call insights highlight strategic growth and client retention but also underline challenges such as client loss and margin impacts. The recent director appointment further supports strategic leadership enhancements.
To see Spark’s full report on PGNY stock, click here.
More about Progyny
YTD Price Performance: 25.55%
Average Trading Volume: 1,855,769
Technical Sentiment Signal: Buy
Current Market Cap: $1.93B
See more insights into PGNY stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue